Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Clinical Features of Acquired Resistance to Anti-PD-1 Therapy in Advanced Melanoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical Features of Acquired Resistance to Anti-PD-1 Therapy in Advanced Melanoma.
Clinical Features of Acquired Resistance to Anti-PD-1 Therapy in Advanced Melanoma. Cancer Immunol Res. 2017 05; 5(5):357-362.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Drug Resistance, Neoplasm
Drug Therapy, Combination
Female
Humans
Kaplan-Meier Estimate
Male
Melanoma
Middle Aged
Programmed Cell Death 1 Receptor
Treatment Outcome